NASDAQ: BTSG

BrightSpring Health Services (BTSG) Stock Analysis & Forecast

Nov 13 close

$71.21−0.24 (−0.3%)

Gekko Brief

AI summaryNov 9 close

BrightSpring climbed this week on the back of its Q3 2026 results, reported on 30 October, which showed revenue of $4.2B, up 26% year over year, adjusted EBITDA of $228 million, up 42%, and EPS of $0.54 against an estimate of $0.47. Pharmacy Solutions revenue rose 26% to $3.7B, with specialty and infusion growth of 34% and script growth of 29%, while Provider Services revenue grew 31% to $481 million. The company raised its 2026 guidance and pointed to continued organic growth into 2027, with coverage noting the stock's 11.3% weekly gain alongside commentary on its valuation relative to peers in the medical services sector.

BTSG closed at $69.15, up 3% on the day, and sits well above both its 50-day average of $60.96 and its 200-day average of $55.54, with the shorter average above the longer one. The GekkoIndex reading of 48.6 places the stock in the Neutral zone. Against a Gekko Fair Value of $62.83, the price stands 10.1% above that level, a gap flagged as a headwind in the latest reading.

The next earnings date falls on 26 February 2027, 108 days out and beyond a typical 20-trading-day hold. No insider, Congress or unusual options activity is recorded in the current windows. Analyst coverage from 9 firms is unanimously rated buy, with a consensus target of $83.21, implying 20.3% upside from current levels. Worth noting is the recent run-up against the fair value gap as the stock digests its post-earnings move.

Written by AI from the Nov 9, 2026 close and checked automatically against the figures on this page.

BrightSpring Health Services price vs fair value

$71.21$64.15Nov ’25May ’26Nov ’26
Close $71.21200-day averageGekko Fair Value $64.15

BrightSpring Health Services quick facts

Market cap
$14.17B
P/E ratio
50.7
Forward P/E
23.2
EPS, TTM
$1.41
Revenue, TTM
$15.25B
Profit margin
2.7%
Dividend yield
—
Beta
1.78
Volume
1.34M avg 2.61M
1-year return
+111.7%
Typical daily move
±4.7%
Typical 20-day move
±9.8%
50-day average
$61.93
200-day average
$56.19
Next earnings
Feb 26 before open
Shares outstanding
199.0M
52-week range
$30.64$73.75

BrightSpring Health Services swing-trade checklist

BrightSpring Health Services scores 2 supportive, 1 mixed and 1 headwind across the 4 checklist items with data.

Six things swing traders check before a 20-day hold, read from the latest data.

2 supportive1 mixed1 headwind

  • Trendsupportive

    Above 50 and 200-day

    Close $71.21 is above the 50-day ($61.93) and 200-day ($56.19) averages, and the 50-day is above the 200-day.

    See the chart
  • GekkoIndexmixed

    48.1, Neutral

    Reading 48.1 is in the Neutral zone.

    See the GekkoIndex
  • Fair valueheadwind

    11.0% above

    Price is 11% above Gekko Fair Value (more than 5% above).

    See fair value
  • Smart moneyno data

    No data

    No insider, Congress or unusual options activity in the window.

    See smart money
  • Earnings risksupportive

    Reports in 103 days

    Next report Feb 26, 2027, 103 days away — outside a typical 20-trading-day hold.

    See earnings
  • Seasonalityno data

    No data

    Not enough years of history for a seasonal read.

A description of current data, not a recommendation. How this page works

BrightSpring Health Services stock chart and price history

BrightSpring Health Services closed at $71.21 on Nov 13, 2026, +111.7% over the past year, inside a 52-week range of $30.64 to $73.75.

Close50-day average200-day averageVolume
BrightSpring Health Services share price, past year, with 50-day and 200-day moving averages and volume$30$40$50$60DecJan 2026FebMarAprMayJunJulAugSepOctNov71.21

Use the left and right arrow keys to read daily values.

Performance Breakdown

1 month
+14.2%
3 months
+17.9%
6 months
+23.0%
1 year
+111.7%
The full BTSG chart adds GekkoIndex, insider, options, Congress and hedge fund markers, plus TrendCandles™.Open BTSG in Gekko

Follow BrightSpring Health Services through every session

Put BTSG on a Gekko watchlist and see its GekkoIndex, Gekko Fair Value and smart money signals update on the chart as they change.

Track BTSG in GekkoFree for 7 days. No credit card required.

About BrightSpring Health Services

BrightSpring Health Services provides healthcare services delivered in patients' homes and local communities across the United States. Its work centers on pharmacy services alongside medical provider support, combining clinical treatment with everyday assistance for those who need it. The company is recognized for bringing this kind of home and community based care to a wide range of patients rather than requiring facility visits.

Care is delivered by clinical staff and licensed pharmacists who work directly with patients. The people served include those covered by Medicare, Medicaid, and private insurance plans, reflecting a customer base that spans public and private payers.

The company was founded in 1974 and is headquartered in Louisville, Kentucky. It previously operated under the name Phoenix Parent Holdings Inc. before adopting its current name, BrightSpring Health Services, Inc., in May 2021. Shares of the company are listed on the NASDAQ under the ticker BTSG.

Listed
NASDAQ
Sector
Health services
Industry
Medical/Nursing services
Website
brightspringhealth.com

BrightSpring Health Services GekkoIndex: the smart money zone

BrightSpring Health Services’s GekkoIndex — Gekko’s 0 to 100 smart money score — reads 48.1, in the Neutral zone, down 1.4 points over five sessions.

010048.1Neutral

Down 1.4 points over five sessions.

Reading for Nov 13, 2026

What followed past readings in each zone

ZoneReadings5 days10 days20 days50 days
Buying15+3.1%+8.2%+6.6%+31.9%
Accumulation160+1.1%+3.7%+10.6%+21.7%
Neutral (current zone)425+1.5%+2.6%+5.0%+15.7%
Distribution89+1.7%+3.1%+4.7%+11.3%
Selling5Too few readings yet

Average BTSG share-price change over the trading days after each daily reading in its GekkoIndex history. Across every stock Gekko tracks, Neutral readings averaged +0.9% over 20 days. Past behaviour doesn’t guarantee future results.

Neutral zone: No clear directional signal. About the five zones →

See every daily GekkoIndex reading plotted over the BTSG price, zone by zone.Track BTSG in Gekko

Is BrightSpring Health Services stock overvalued? Gekko Fair Value

BrightSpring Health Services trades 11.0% above Gekko Fair Value of $64.15, so the shares are overvalued on Gekko’s estimate.

Gekko’s own estimate of what BrightSpring Health Services shares are worth, recalculated every trading day.

$64.15

Gekko Fair Value, Nov 14, 2026

11.0% Overvalued

At the end of Sep 2026 the price was 8.5% below the estimate.

Gekko Fair ValueShare price, month end
$64$71Sep 2026OctNov 2026

How Gekko Fair Value works →

Gekko Fair Value on every chart, with the gap to price updating daily.Open BTSG in Gekko

BrightSpring Health Services insider and Congress trading

No open-market insider purchases were filed for BrightSpring Health Services, and no Congress trades were disclosed, in the last 90 days.

Plus buybacks, unusual options and fund positions, each dated to when it became public.

Insider buying last 90 days

No open-market insider purchases were filed for BTSG in the last 90 days.

From Form 4 filings, dated to when each was filed.

Every BTSG insider filing, plotted on the chart in Gekko.Open BTSG in Gekko

Congress trades last 90 days

No trades in BTSG were disclosed by members of Congress in the last 90 days.

From congressional disclosures, which report amounts as ranges.

Congress disclosures for BTSG, plotted on the chart in Gekko.Open BTSG in Gekko

Buybacks

BrightSpring Health Services has been buying back its own shares.

Bought back, quarter ended Jun 30, 2026
$60.00M
As a share of market cap
0.42%

From company filings.

Hedge funds and billionaires quarter ended Jun 30

2of the funds Gekko tracks hold BTSG.

0added1opened1trimmed0sold out
Which funds are on each side, name by name.Unlock in Gekko

BrightSpring Health Services earnings: next date and track record

BrightSpring Health Services reports on Feb 26, 2027, before the open (103 days away), and beat the EPS estimate in 6 of its last 8 reports.

6 of 8reports beat the EPS estimate
±10.1%average move across the report
6 of 8reports followed by a gain

Share-price move across each report

+12.3%Nov ’24+18.2%May ’25−6.2%Aug ’25+2.1%Oct ’25+3.6%Feb ’26+11.6%May ’26−17.0%Jul ’26+10.0%Oct ’26

Last earnings call, Oct 30, 2026 AI summary

What they said
BrightSpring (BTSG) reported Q3 2026 revenue of $4.2B, up 26% YoY, and adjusted EBITDA of $228M, up 42% YoY. EPS of $0.54 grew 80% YoY and 20% sequentially. Cash flow from operations exceeded $200M. Pharmacy Solutions revenue rose 26% to $3.7B with 34% specialty/infusion growth and 29% script growth. Provider Services revenue grew 31% to $481M. The company launched 7 new LDDs in Q3, totaling 19 year-to-date.
Guidance
Management did not provide explicit forward guidance in this excerpt. Growth trajectory remains strong with double-digit expansion across segments, supported by LDD launches, M&A activity, and demographic tailwinds driving demand for home-based care services.
ReportedEPSSurpriseRevenueSurpriseMove
Oct 30, 2026$0.54
est $0.47
+14.2%$4.21B
est $3.88B
+8.7%+10.0%
Jul 31, 2026$0.45
est $0.37
+21.6%$3.87B
est $3.66B
+5.8%−17.0%
May 1, 2026$0.39
est $0.31
+26.1%$3.61B
est $3.39B
+6.6%+11.6%
Feb 27, 2026$0.33
est $0.25
+32.0%$3.55B
est $3.38B
+5.0%+3.6%
Oct 31, 2025$0.30
est $0.26
+13.9%$3.33B
est $3.17B
+5.3%+2.1%
Aug 1, 2025$0.13
est $0.22
−40.9%$3.15B
est $3.17B
−0.6%−6.2%
May 2, 2025$0.19
est $0.08
+137.5%$2.88B
est $2.90B
−0.9%+18.2%
Nov 1, 2024$0.11
est $0.17
−35.3%$2.91B
est $2.94B
−1.1%+12.3%

“Move” is the close of the first session after the report compared with the close of the last session before it, so it reads the same whether the company reported before the open or after the close.

BrightSpring Health Services stock forecast and analyst price targets

Analysts’ average 12-month price target for BrightSpring Health Services is $83.21, +16.9% from the last close, from 9 firms rating the stock in the last 90 days.

$83.21consensus 12-month target, +16.9% from the last close
Low $79High $92
Buy9
Hold0
Sell0

Each firm’s latest rating in the last 90 days: 9 firms.

Latest analyst actions

DateFirmRatingTargetvs price
Nov 3Morgan StanleyBuy, reiterated$80+12.3%
Nov 2UBSBuy, maintained$92+29.2%
Nov 2Leerink PartnersBuy, reiterated$92+29.2%
Nov 2TD CowenBuy, reiterated$84+18.0%
Nov 2Wells FargoBuy, reiterated$82+15.2%
+5.0%average 20-day move after past Neutral readings
±4.7%typical daily move, from the 14-day average range

Gekko doesn’t publish price predictions. These are analyst targets and historical base rates, which don’t guarantee future results.

BrightSpring Health Services market cap and key statistics

BrightSpring Health Services’s market cap is $14.17B, with a P/E ratio of 50.7 and revenue of $15.25B over the last twelve months.

Valuation

Market cap
$14.17B
P/E ratio
50.7
Forward P/E
23.2
EPS, TTM
$1.41
Gekko Fair Value
$64.15

Trading

Volume
1.34M
Avg volume, 20 days
2.61M
52-week high
$73.75
52-week low
$30.64
Shares outstanding
199.0M

Financials

Revenue, TTM
$15.25B
Profit margin
2.7%
Return on equity
15.5%
Quarterly earnings growth, YoY
+82.0%

Risk and income

Beta
1.78
Typical daily move
±4.7%
Typical 20-day move
±9.8%

BrightSpring Health Services stock news this week

3 headlines about BrightSpring Health Services from the past week, newest first, each linking to the publisher.

BrightSpring Health Services peers

BrightSpring Health Services’s 6 largest industry peers by market value, with today’s move, GekkoIndex zone and gap to Gekko Fair Value.

StockTodayGekkoIndex zonevs Fair Value
LHLabcorp−1.0%Neutral8.5% above
GHGuardant Health−2.8%Accumulation16.4% below
SOLVSolventum0.0%Neutral17.0% below
EHCEncompass Health−0.4%Neutral14.7% above
ENSGEnsign+0.3%Neutral15.6% above
DVADaVita−0.3%Accumulation25.6% below

A peer links to its own page where one exists.

In the Buying zone today

Reporting earnings this week

Popular on Gekko

More stocks in Medical/Nursing services

BrightSpring Health Services stock FAQ

What is BrightSpring Health Services’s market cap?

BrightSpring Health Services’s market cap is $14.17B at the Nov 13, 2026 close of $71.21, with 199.0M shares outstanding. The shares trade on a P/E ratio of 50.7.

What is the BrightSpring Health Services stock forecast?

The consensus analyst 12-month price target for BrightSpring Health Services is $83.21, +16.9% from the last close. Of the 9 firms that rated the stock in the last 90 days, 9 rate it a buy, 0 a hold and 0 a sell. Gekko doesn’t publish price predictions of its own.

Is BrightSpring Health Services stock overvalued or undervalued?

On Gekko’s estimate BrightSpring Health Services is overvalued: the Nov 13, 2026 close of $71.21 is 11.0% above Gekko Fair Value of $64.15. Gekko Fair Value is recalculated every trading day, and a gap inside 5% either way counts as about fair value.

When does BrightSpring Health Services report earnings next?

BrightSpring Health Services is expected to report on Feb 26, 2027, before the market opens (103 days away). Analysts expect earnings of $0.56 per share on revenue of $4.35B. BrightSpring Health Services beat the earnings estimate in 6 of its last 8 reports, moving 10.1% on average across the report.

What is BrightSpring Health Services’s 52-week high and low?

BrightSpring Health Services’s 52-week high is $73.75 and its 52-week low is $30.64; it closed at $71.21 on Nov 13, 2026, +111.7% over the past year.

Is BrightSpring Health Services stock a buy right now?

Gekko describes the data; it does not make buy or sell recommendations. On the swing-trade checklist, 2 of the 4 items with data read as supportive (trend and earnings risk), 1 as mixed (gekkoindex) and 1 as a headwind (fair value). The checklist is a description of current data, not a recommendation.

How this page works

During US trading hours the price at the top of the page is a delayed quote, refreshed every 15 minutes; everything else is rebuilt after each US market close. The GekkoIndex, Gekko Fair Value and the checklist are Gekko’s own, and the Gekko Brief is written by AI from this page’s data and checked against it before it is published. How Gekko’s data works →

See BrightSpring Health Services the way Gekko members do

Every GekkoIndex reading, insider trade, options bet and Congress disclosure plotted on the chart, plus the 5,800-name screener and trade planning tools.

Join 1,475 other traders using Gekko

Start Your FREE 7 Day Trial → Every feature unlocked. No credit card required.